We found that nine guidelines recommended systemic corticosteroids universally to all AECOPD patients, and the Spanish guideline reserved such treatment to all patients with an at least moderate exacerbation (without providing information about different severity grades). One guideline reserved such ...
26]. Approximately 50% of patients die within 3.6 years of their first severe (hospitalised) exacerbation [26], and there is an 80% increase in the risk of death in patients who have experienced two moderate (community-treated) exacerbations...
The peak expiratory flow (PEF) is commonly obtained and is generally used as a dynamic measure for monitoring severity of airflow obstruction during an exacerbation. A protocol using PEF and a simple symptom based score identified patients with COPD in the primary care setting [112], and handhel...
(FEV1) ,60% predicted or exacerbation risk, in primary care settings.1,2 This case- finding method uses five simple patient-completed questions and the selective use of peak expiratory flow (PEF) to uncover individuals most likely to benefit from diagnosis and treatment.1–8 The intent is to...
“An important thing to take away about asthma management is that inhaled corticosteroid treatment is by far the first line therapy for patients with asthma and our goal is symptom free and normal pulmonary function tests,” she said. The least a...
(FEV1) ,60% predicted or exacerbation risk, in primary care settings.1,2 This case- finding method uses five simple patient-completed questions and the selective use of peak expiratory flow (PEF) to uncover individuals most likely to benefit from diagnosis and treatment.1–8 The intent is to...
Clinicians questioned whether to treat COPD patients in the presence or absence of COVID-19 with inhaled corticosteroids for maintenance therapy and systemic corticosteroids for exacerbation treatment [94,95]. Corticosteroids are immunosuppressants, and numerous studies have found that there is an ...